Shiver J W, Su L, Henkart P A
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Cell. 1992 Oct 16;71(2):315-22. doi: 10.1016/0092-8674(92)90359-k.
The noncytotoxic rat mast cell tumor line RBL was transfected with genes for the cytotoxic lymphocyte granule proteins cytolysin (perforin) and granzyme A, giving transfectants with mRNA and protein expression levels comparable with cloned cytotoxic T lymphocytes. Both RBL-cytolysin and RBL-cytolysin-granzyme A transfectants showed extremely potent killing of red cell targets and lysed 20%-60% of EL4 lymphoma targets at an effector-to-target ratio of 30. RBL transfectants expressing only granzyme A were not cytotoxic. Significant EL4 DNA breakdown accompanying lysis was observed only with RBL that was transfected with both cytolysin and granzyme A. These results support the granule-exocytosis model for lymphocyte cytotoxicity and show that effector granzyme A plays a role in target cell DNA breakdown.
将细胞毒性淋巴细胞颗粒蛋白溶细胞素(穿孔素)和颗粒酶A的基因转染至无细胞毒性的大鼠肥大细胞瘤细胞系RBL,得到的转染子其mRNA和蛋白质表达水平与克隆的细胞毒性T淋巴细胞相当。RBL-溶细胞素和RBL-溶细胞素-颗粒酶A转染子均对红细胞靶标表现出极强的杀伤作用,在效应细胞与靶标细胞比例为30时,可裂解20%-60%的EL4淋巴瘤靶标。仅表达颗粒酶A的RBL转染子无细胞毒性。仅在同时转染了溶细胞素和颗粒酶A的RBL中观察到伴随裂解出现的显著的EL4 DNA降解。这些结果支持淋巴细胞细胞毒性的颗粒胞吐模型,并表明效应性颗粒酶A在靶细胞DNA降解中发挥作用。